Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Rho kinase inhibitor for treatment of Fuchs endothelial corneal dystrophy
TCTR20250107001Phase 3Completed
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Apr 2025
- Countries
- 1
01
Overview
Phase 3 trial in Fuchs endothelial dystrophy (FED), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Apr 2025; status: completed.
02
Conditions
Fuchs endothelial dystrophy (FED)
Beyond the preview
Go deeper on TCTR20250107001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250107001.